These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34778306)

  • 41. Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease.
    Traber PG; Chou H; Zomer E; Hong F; Klyosov A; Fiel MI; Friedman SL
    PLoS One; 2013; 8(10):e75361. PubMed ID: 24130706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic prediction of the platelet-to-lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.
    Li DZ; Guo J; Song QK; Hu XJ; Bao XL; Lu J
    Transl Cancer Res; 2022 Nov; 11(11):4037-4050. PubMed ID: 36523315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis.
    Yan LJ; Yao SY; Meng GX; Liu KX; Li HC; Ding ZN; Dong ZR; Hong JG; Chen ZQ; Li T
    Hepatol Int; 2021 Dec; 15(6):1413-1420. PubMed ID: 34478116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis.
    Huang ZH; Lu GY; Qiu LX; Zhong GH; Huang Y; Yao XM; Liu XH; Huang SJ; Wu T; Yuan Q; Wang YB; Su YY; Zhang J; Xia NS
    BMC Cancer; 2022 Mar; 22(1):287. PubMed ID: 35300634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers to predict relapse and survival in posthepatectomy HBV-related hepatocellular carcinoma: a meta-analysis and preliminary immune perspective.
    Zheng X; Ye B; Gou Y; Li Z; Chen C; Liao F; Liu X; Qin S
    Transl Cancer Res; 2021 Mar; 10(3):1261-1272. PubMed ID: 35116453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sarcopenia Predicts Prognosis of Patients Undergoing Liver Resection for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Zhang H; Zhang L; Wang Y; Zou J; Zhang T
    Nutr Cancer; 2023; 75(3):776-784. PubMed ID: 36537813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of RASSF1A hypermethylation with risk of HBV/HCV-induced hepatocellular carcinoma: A meta-analysis.
    Peng JL; Wu JZ; Li GJ; Wu JL; Xi YM; Li XQ; Wang L
    Pathol Res Pract; 2020 Oct; 216(10):153099. PubMed ID: 32853942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy for the unresectable hepatocellular carcinoma and the benefit for hepatitis B virus etiology subgroup: a systematic review and meta-analysis of randomized controlled trials.
    Huang D; Ke L; Cui H; Li S
    BMC Cancer; 2023 May; 23(1):474. PubMed ID: 37226111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
    Li J; Gao JZ; Du JL; Wei LX
    World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis: HCC and Steatosis or Steatohepatitis.
    Petrelli F; Manara M; Colombo S; De Santi G; Ghidini M; Mariani M; Iaculli A; Rausa E; Rampulla V; Arru M; Viti M; Lonati V; Ghidini A; Luciani A; Facciorusso A
    Neoplasia; 2022 Aug; 30():100809. PubMed ID: 35636146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of serum interleukin-10 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis.
    Shakiba E; Ramezani M; Sadeghi M
    Clin Exp Hepatol; 2018 Mar; 4(1):35-40. PubMed ID: 29594196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Different Prognoses of Hepatocellular Carcinoma with Previous Tenofovir versus Entecavir Treatment for Chronic Hepatitis B Virus: Analysis Based on 15 Propensity Score-Matched Studies.
    Hou J; Qiang Z; Li Y; Zhang Y
    Dig Dis; 2023; 41(3):476-488. PubMed ID: 36535244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating galectin-3 on admission and prognosis in acute heart failure patients: a meta-analysis.
    Chen H; Chen C; Fang J; Wang R; Nie W
    Heart Fail Rev; 2020 Mar; 25(2):331-341. PubMed ID: 31641977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of the CRAFITY score in hepatocellular carcinoma treated with immunotherapy: a systematic review and meta-analysis.
    Yang M; Pan Y; Wang W
    BMC Cancer; 2023 Mar; 23(1):236. PubMed ID: 36915049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus: A Reconstructed Individual Patient Data Meta-analysis.
    Tan DJH; Ng CH; Tay PWL; Syn N; Muthiah MD; Lim WH; Tang ASP; Lim KE; Lim GEH; Tamaki N; Kim BK; Teng MLP; Fung J; Loomba R; Nguyen MH; Huang DQ
    JAMA Netw Open; 2022 Jun; 5(6):e2219407. PubMed ID: 35767258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma.
    Liang C; Xu Y; Ge H; Li G; Wu J
    Onco Targets Ther; 2018; 11():1203-1214. PubMed ID: 29551899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis.
    Luo Y; Ren F; Liu Y; Shi Z; Tan Z; Xiong H; Dang Y; Chen G
    Int J Clin Exp Med; 2015; 8(7):10235-47. PubMed ID: 26379815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic and clinicopathological significance of MACC1 expression in hepatocellular carcinoma patients: a meta-analysis.
    Sun DW; Zhang YY; Qi Y; Liu GQ; Chen YG; Ma J; Lv GY
    Int J Clin Exp Med; 2015; 8(4):4769-77. PubMed ID: 26131051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma.
    Xu XS; Qu K; Liu C; Zhang YL; Liu J; Song YZ; Zhang P; Liu SN; Chang HL
    World J Gastroenterol; 2012 Dec; 18(48):7242-50. PubMed ID: 23326129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The roles of galectins in hepatic diseases.
    Sun MJ; Cao ZQ; Leng P
    J Mol Histol; 2020 Oct; 51(5):473-484. PubMed ID: 32734557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.